PPT-Countries using and planning to introduce IPV

a nd the global status of bOPV registration Countries using and planning to introduce IPV October 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine IPV . Countries using and planning to introduce IPV. June 2015 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . Countries using and planning to introduce IPV. April 2015 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . Countries using and planning to introduce IPV. July 2015 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . Part 1: Technical Rationale for IPV Introduction and OPV Withdrawal. GPEI Accomplishment . Significant Decline in Paralysis Due to WPVs, 1988 to 2013*. Poliovirus Types. IPV. Number of Cases of cVDPV-related Polio Exceeds the Number of Cases of WPV. Assistance Program . Department of Veterans Affairs. Jennifer Broomfield, LISW, JD. Program Manager, DV/IPV Assistance Program. Care Management and Social Work Services. Veterans Health Administration. Rationale and Programmatic Implications for Objective 2 of The Polio Eradication and Endgame Strategic Plan. Immunization Systems Management Group (IMG). Version date: February 10, 2014. Glossary of terms & abbreviations. Comprehensive technical module. R. ationale for IPV introduction & OPV withdrawal in relation to Objective 2 of The Polio Eradication & Endgame Strategic Plan. Immunization Systems Management Group (IMG). and the global status of . bOPV. registration. Countries using and planning to introduce IPV. March 2016 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . August 2014 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact . Rationale and Programmatic Implications for Objective 2 of The Polio Eradication and Endgame Strategic Plan. Immunization Systems Management Group (IMG). 25 March 2014. . Glossary of terms & abbreviations. 䠀椀渀攀Ⰰ 䈀攀渀樀愀洀椀渀Ⰰ 一漀欀甀Ⰰ 䰀攀搀樀愀Ⰰ 䈀愀琀攀猀Ⰰ 䔀氀椀稀愀戀攀琀栀 愀渀搀 䨀愀礀攀猀Ⰰ 䬀攀愀氀攀礀 ⠀㈀　 Linda Madigan Runlett. MST-IPV Pilot Highlights. 2014 – Talks began between DCF and Dr. Schaeffer & Dr. Swenson (model . developers of . MST-BSF) to develop a new innovative treatment model addressing families impacted by intimate partner violence. Initial white paper developed by Dr. Schaeffer & Dr. Swenson (October, 2014). IPV is a vaccine given with the third dose of Oral Polio Vaccine (OPV), when your IPV plus OPV provides your child with the best protection from polio. Can I delay the IPV or any of the scheduled vac Audrey Pettifor PhD. University of North Carolina at Chapel Hill. Social determinants that increase risk. Education/Schooling. Poverty. Gender Inequity/Violence. Mental Health. Alcohol/Drugs. Randomized Controlled Trial.